Compass Therapeutics, Inc.
CMPX
$5.28
$0.061.15%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -65.81M | -62.03M | -55.22M | -49.38M | -47.76M |
| Total Depreciation and Amortization | 1.46M | 1.56M | 1.65M | 1.75M | 1.86M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.03M | 9.09M | 7.82M | 6.91M | 5.73M |
| Change in Net Operating Assets | 11.26M | 6.13M | 1.57M | -4.14M | -7.88M |
| Cash from Operations | -45.05M | -45.25M | -44.18M | -44.86M | -48.05M |
| Capital Expenditure | -25.00K | -62.00K | -62.00K | -44.00K | -53.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -74.53M | 49.68M | 62.52M | 46.82M | 37.77M |
| Cash from Investing | -74.56M | 49.62M | 62.46M | 46.77M | 37.72M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 138.00M | 0.00 | 0.00 | 18.11M | 18.11M |
| Repurchase of Common Stock | -911.00K | -911.00K | -911.00K | -232.00K | -295.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.64M | 0.00 | 1.00K | -543.00K | -544.00K |
| Cash from Financing | 128.45M | -911.00K | -910.00K | 17.34M | 17.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.84M | 3.45M | 17.37M | 19.26M | 6.94M |